Developing new drugs to treat COVID-19
SARS-CoV-2 protease inhibitors for treating COVID-19
This study is working on new medications to help people with COVID-19 by targeting specific parts of the virus that help it grow, aiming to make treatments more effective and reduce the severity of the illness.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Purdue University NIH-funded |
| Lab location | 1 site (West Lafayette, United States) |
| Project ID | NIH-10669064 on NIH RePORTER |
What this research studies
This research focuses on creating novel protease inhibitors that target the SARS-CoV-2 virus, which causes COVID-19. The team aims to build on previous findings to develop effective antiviral medications that can reduce the severity of the disease. By targeting specific enzymes critical for the virus's replication, the research seeks to provide new treatment options for patients suffering from COVID-19. The approach involves extensive laboratory work and collaboration to ensure the efficacy and safety of these potential drugs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with COVID-19, particularly those experiencing severe symptoms.
Not a fit: Patients who have mild or asymptomatic COVID-19 may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective antiviral treatments for COVID-19, potentially reducing hospitalizations and mortality rates.
How similar studies have performed: Previous research on protease inhibitors for coronaviruses like SARS and MERS has shown promising results, indicating potential success for this approach.
Where this research is happening
West Lafayette, United States
- Purdue University — West Lafayette, United States (Active)
Researchers
- Principal investigator: Ghosh, Arun K — Purdue University
- Study coordinator: Ghosh, Arun K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.